Citation analysis for PharmacoEconomics / Springer

Citation Profile [Updated: 2025-01-21 17:37:07]

5 Years H Index

Impact Factor (IF)

0.12

5 Years IF

0.11

Data available in this report

[Raw data] [50 most cited papers] [50 most relevant papers] [cites used to compute IF] [Recent citations ][Frequent citing series ] [more data in EconPapers] [trace new citations] [Missing citations? Add them now] [Incorrect content? Let us know]

Main indicators

Raw Data

	IF	AIF	CIF	IF5	DOC	CDO	CIT	NCI	CCU	D2Y	C2Y	D5Y	C5Y	SC	%SC	CiY	II	AII
1997	0	0.24	0	0	10	10	17		1	0		0			0		0	0.11
1998	0	0.28	0	0	12	22	8		1	10		10			0		0	0.13
2000	0	0.36	0	0	9	31	15		6	12		22			0		0	0.16
2001	0	0.39	0.09	0.1	3	34	4	3	9	9		31	3	2	66.7		0	0.17
2003	0	0.44	0.13	0.13	5	39	13	5	17	3		24	3	1	20		0	0.22
2004	0.2	0.49	0.08	0.12	1	40	3	3	20	5	1	17	2		0		0	0.22
2005	0	0.51	0.02	0	7	47	14	1	21	6		18			0		0	0.24
2006	0	0.51	0.16	0.06	62	109	125	17	38	8		16	1	15	88.2	13	0.21	0.23
2007	0.09	0.46	0.08	0.09	38	147	93	12	50	69	6	75	7	5	41.7	2	0.05	0.2
2008	0.07	0.49	0.07	0.08	22	169	272	11	61	100	7	113	9	4	36.4		0	0.23
2009	0.18	0.48	0.1	0.12	28	197	80	20	81	60	11	130	16	8	40	1	0.04	0.24
2010	0.42	0.48	0.22	0.26	33	230	78	50	131	50	21	157	41	11	22		0	0.21
2011	0.13	0.52	0.18	0.16	32	262	121	46	177	61	8	183	30	16	34.8	5	0.16	0.24
2012	0.42	0.52	0.36	0.39	93	355	183	127	304	65	27	153	59	64	50.4	26	0.28	0.22
2013	0.3	0.56	0.27	0.3	96	451	437	120	424	125	37	208	63	37	30.8	27	0.28	0.24
2014	0.19	0.55	0.19	0.18	110	561	365	108	532	189	35	282	52	29	26.9	18	0.16	0.23
2015	0.31	0.55	0.27	0.27	105	666	352	183	715	206	63	364	99	31	16.9	16	0.15	0.23
2016	0.27	0.52	0.24	0.26	133	799	272	195	910	215	57	436	114	36	18.5	12	0.09	0.21
2017	0.27	0.54	0.27	0.25	116	915	283	246	1157	238	65	537	135	60	24.4	28	0.24	0.22
2018	0.26	0.55	0.28	0.3	128	1043	175	294	1451	249	65	560	168	40	13.6	11	0.09	0.23
2019	0.28	0.56	0.31	0.27	132	1175	208	366	1817	244	68	592	158	60	16.4	33	0.25	0.23
2020	0.22	0.67	0.32	0.28	118	1293	85	417	2234	260	58	614	174	34	8.2	14	0.12	0.32
2021	0.22	0.79	0.3	0.23	114	1407	67	421	2655	250	56	627	142	38	9	18	0.16	0.29
2022	0.2	0.83	0.27	0.24	120	1527	36	411	3066	232	47	608	143	25	6.1	22	0.18	0.25
2023	0.1	0.82	0.18	0.15	86	1613	15	288	3354	234	24	612	89	8	2.8	3	0.03	0.23
2024	0.12		0.13	0.11	55	1668	0	219	3573	206	25	570	62	5	2.3		0

IF:	Two years Impact Factor: C2Y / D2Y
AIF:	Average Impact Factor for all series in RePEc in year y
CIF:	Cumulative impact factor
IF5:	Five years Impact Factor: C5Y / D5Y
DOC:	Number of documents published in year y
CDO:	Cumulative number of documents published until year y
CIT:	Number of citations to papers published in year y
NCI:	Number of citations in year y
CCU:	Cumulative number of citations to papers published until year y
D2Y:	Number of articles published in y-1 plus y-2
C2Y:	Cites in y to articles published in y-1 plus y-2
D5Y:	Number of articles published in y-1 until y-5
C5Y:	Cites in y to articles published in y-1 until y-5
SC:	selft citations in y to articles published in y-1 plus y-2
%SC:	Percentage of selft citations in y to articles published in y-1 plus y-2
CiY:	Cites in year y to documents published in year y
II:	Immediacy Index: CiY / Documents.
AII:	Average Immediacy Index for series in RePEc in year y

50 most cited documents in this series

#	Year	Title	Cited
1	2013	Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers \|\| Download paper	242
2	2008	Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers \|\| Download paper	205
3	2014	Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers \|\| Download paper	90
4	2019	Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Ellis, Alan R ; Bekker-Grob, Esther W ; Soekhai, Vikas. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers \|\| Download paper	77
5	2017	Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers \|\| Download paper	69
6	2016	Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers \|\| Download paper	48
7	2015	The Epidemiology of Obesity: A Big Picture. (2015). Hruby, Adela ; Hu, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. Full description at Econpapers \|\| Download paper	44
8	2013	How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers \|\| Download paper	36
9	2015	The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Archangelidi, Olga ; Seuring, Till. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers \|\| Download paper	35
10	2014	A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers \|\| Download paper	34
11		Effects of Reference Pricing in Pharmaceutical Markets. (2011). Miraldo, Marisa ; Galizzi, Matteo ; Ghislandi, Simone. In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:1:p:17-33. Full description at Econpapers \|\| Download paper	33
12	2016	EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers \|\| Download paper	33
13	2014	Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers \|\| Download paper	30
14	2015	Savings in Medical Expenditures Associated with Reductions in Body Mass Index Among US Adults with Obesity, by Diabetes Status. (2015). Meyerhoefer, Chad ; Cawley, John ; Biener, Adam ; Hammer, Mette ; Wintfeld, Neil . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:707-722. Full description at Econpapers \|\| Download paper	28
15	2012	Golimumab for the Treatment of Psoriatic Arthritis. (2012). Sculpher, Mark ; EPSTEIN, DAVID ; Bruce, Ian ; Yang, Huiqin ; Craig, Dawn ; Woolacott, Nerys ; Bojke, Laura ; Light, Kate . In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:4:p:257-270. Full description at Econpapers \|\| Download paper	26
16	2009	Cost Effectiveness in Low- and Middle-Income Countries. (2009). Walker, Damian ; Goodman, Catherine ; Mills, Anne ; Shillcutt, Samuel . In: PharmacoEconomics. RePEc:spr:pharme:v:27:y:2009:i:11:p:903-917. Full description at Econpapers \|\| Download paper	25
17	2017	The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers \|\| Download paper	25
18	2014	How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers \|\| Download paper	24
19	2015	The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration. (2015). Gray, Alastair ; Froud, Robert ; Longworth, Louise ; Dakin, Helen ; Rivero-Arias, Oliver ; Petrou, Stavros ; Oppe, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:993-1011. Full description at Econpapers \|\| Download paper	23
20	2017	International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers \|\| Download paper	20
21	2015	A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers \|\| Download paper	20
22	2014	Preferences for Oral Anticoagulants in Atrial Fibrillation: a BestâBest Discrete Choice Experiment. (2014). Lancsar, Emily ; Ghijben, Peter ; Zavarsek, Silva. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:11:p:1115-1127. Full description at Econpapers \|\| Download paper	19
23	2014	Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime ; Neasham, David ; Lanitis, Tereza . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers \|\| Download paper	19
24	2015	Does Including Informal Care in Economic Evaluations Matter? A Systematic Review of Inclusion and Impact of Informal Care in Cost-Effectiveness Studies. (2015). van Exel, Job ; Krol, Marieke ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:2:p:123-135. Full description at Econpapers \|\| Download paper	19
25	2018	German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; J-Matthias Graf von der Schulenburg, ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers \|\| Download paper	18
26	2014	The Value of a QALY: Individual Willingness to Pay for Health Gains Under Risk. (2014). van Exel, Job ; Brouwer, Werner ; Bobinac, Ana. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:1:p:75-86. Full description at Econpapers \|\| Download paper	18
27	2018	Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Cheng, Terence ; Ali, Hossein Haji ; Edney, Laura Catherine ; Karnon, Jonathan. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2. Full description at Econpapers \|\| Download paper	17
28	2018	Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers \|\| Download paper	17
29	2018	A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. Full description at Econpapers \|\| Download paper	17
30	2015	Reimbursement Decisions for Pharmaceuticals in Sweden: The Impact of Disease Severity and Cost Effectiveness. (2015). Svensson, Mikael ; Arnberg, Karl ; Nilsson, Fredrik. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:11:p:1229-1236. Full description at Econpapers \|\| Download paper	17
31	2018	Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Bonsel, Gouke J ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers \|\| Download paper	16
32	2011	Do Productivity Costs Matter?. (2011). Brouwer, Werner ; Krol, Marieke ; Koopmanschap, Marc ; Papenburg, Joce . In: PharmacoEconomics. RePEc:spr:pharme:v:29:y:2011:i:7:p:601-619. Full description at Econpapers \|\| Download paper	16
33	2019	Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Deshpande, Abhishek ; Zhang, LU ; Nghiem, Van T ; Chiyaka, Edward T ; Le, Phuc ; Mullen, Patricia Dolan. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers \|\| Download paper	16
34	2010	Using Conjoint Analysis and Choice Experiments to Estimate QALY Values. (2010). Flynn, Terry. In: PharmacoEconomics. RePEc:spr:pharme:v:28:y:2010:i:9:p:711-722. Full description at Econpapers \|\| Download paper	15
35	2015	Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review. (2015). Viney, Rosalie ; Sermet, Catherine ; Parkinson, Bonny ; Crausaz, Steffan ; Clement, Fiona ; Elshaug, Adam ; Lopert, Ruth ; Pearson, Sallie-Anne ; Choudhury, Moni ; Garner, Sarah ; Godman, Brian. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:9:p:905-924. Full description at Econpapers \|\| Download paper	15
36	2016	Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial. (2016). Kim, Jane J ; Verguet, Stephane ; Jamison, Dean T. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:9:d:10.1007_s40273-016-0414-z. Full description at Econpapers \|\| Download paper	14
37	2012	Losing Sight of the Wood for the Trees. (2012). Peasgood, Tessa ; Dolan, Paul ; Lee, Henry. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:11:p:1035-1049. Full description at Econpapers \|\| Download paper	14
38	2013	Operationalizing Value-Based Pricing of Medicines. (2013). Towse, Adrian ; Devlin, Nancy ; Sussex, Jon. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:1:p:1-10. Full description at Econpapers \|\| Download paper	14
39	2012	Valuation of the Child Health Utility 9D Index. (2012). Stevens, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:729-747. Full description at Econpapers \|\| Download paper	14
40	2014	Estimating QALY Gains in Applied Studies: A Review of Cost-Utility Analyses Published in 2010. (2014). Klemp, Marianne ; Olsen, Jan ; Hagen, Gunhild ; Movik, Espen ; Hamidi, Vida ; Wisloff, Torbjorn. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:367-375. Full description at Econpapers \|\| Download paper	14
41		Overview of Parametric Survival Analysis for Health-Economic Applications. (2013). Kreif, Noemi ; Muszbek, Noemi ; Ishak, K. ; Benedict, Agnes. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:8:p:663-675. Full description at Econpapers \|\| Download paper	13
42		The Impact of the Urban Resident Basic Medical Insurance on Health Services Utilisation in China. (2014). Chen, Gang ; Liu, Gordon ; Xu, Fei. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:3:p:277-292. Full description at Econpapers \|\| Download paper	13
43	2018	Differential Pricing of Pharmaceuticals: Theory, Evidence and Emerging Issues. (2018). Danzon, Patricia. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0696-4. Full description at Econpapers \|\| Download paper	13
44	2016	From Good to Better: New Dutch Guidelines for Economic Evaluations in Healthcare. (2016). Brouwer, Werner ; Knies, Saskia ; Versteegh, Matthijs. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:11:d:10.1007_s40273-016-0431-y. Full description at Econpapers \|\| Download paper	12
45	2006	Impacts of Cost Containment Strategies on Pharmaceutical Expenditures of the National Health Insurance in Taiwan, 1996â2003. (2006). Huang, Yu-Tung ; Chen, Sun-Bing ; Yang, Ming-Chin ; Liu, Chien-Hsiang ; Lee, Yue-Chune. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:891-902. Full description at Econpapers \|\| Download paper	12
46	2017	Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature. (2017). Krahn, Murray ; Fenwick, Elisabeth ; Koffijberg, Hendrik ; Ijzerman, Maarten J. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0509-1. Full description at Econpapers \|\| Download paper	12
47	2007	Rates and Probabilities in Economic Modelling. (2007). Fleurence, Rachael ; Hollenbeak, Christopher . In: PharmacoEconomics. RePEc:spr:pharme:v:25:y:2007:i:1:p:3-6. Full description at Econpapers \|\| Download paper	12
48	2012	Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001â7. (2012). Lichtenberg, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:3:p:197-211. Full description at Econpapers \|\| Download paper	12
49	2008	Generic Entry, Reformulations and Promotion of SSRIs in the US. (2008). Donohue, Julie ; Huskamp, Haiden ; Berndt, Ernst ; Koss, Catherine ; Frank, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:7:p:603-616. Full description at Econpapers \|\| Download paper	12
50	2006	Using Discrete Choice Experiments within a Cost-Benefit Analysis Framework. (2006). McIntosh, Emma. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:9:p:855-868. Full description at Econpapers \|\| Download paper	12

50 most relevant documents in this series (papers most cited in the last two years)

#	Year	Title	Cited
1	2008	Conducting Discrete Choice Experiments to Inform Healthcare Decision Making. (2008). Lancsar, Emily ; Louviere, Jordan. In: PharmacoEconomics. RePEc:spr:pharme:v:26:y:2008:i:8:p:661-677. Full description at Econpapers \|\| Download paper	27
2	2019	Discrete Choice Experiments in Health Economics: Past, Present and Future. (2019). Vass, Caroline ; Ellis, Alan R ; Bekker-Grob, Esther W ; Soekhai, Vikas. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0734-2. Full description at Econpapers \|\| Download paper	23
3	2014	Discrete Choice Experiments in Health Economics: A Review of the Literature. (2014). Clark, Michael ; Bekker-Grob, Esther ; Determann, Domino ; Moro, Domenico ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:9:p:883-902. Full description at Econpapers \|\| Download paper	16
4	2015	The Epidemiology of Obesity: A Big Picture. (2015). Hruby, Adela ; Hu, Frank. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:7:p:673-689. Full description at Econpapers \|\| Download paper	12
5	2017	Discrete Choice Experiments: A Guide to Model Specification, Estimation and Software. (2017). Lancsar, Emily ; Hole, Arne ; Fiebig, Denzil. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:7:d:10.1007_s40273-017-0506-4. Full description at Econpapers \|\| Download paper	12
6	2016	EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes. (2016). Shah, Koonal ; Ramosgoi, Juan M ; Rand-Hendriksen, Kim ; Oppe, Mark ; Luo, Nan. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:10:d:10.1007_s40273-016-0404-1. Full description at Econpapers \|\| Download paper	12
7	2013	How to Include Informal Care in Economic Evaluations. (2013). van Exel, Job ; Brouwer, Werner ; Hoefman, Renske. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:12:p:1105-1119. Full description at Econpapers \|\| Download paper	11
8	2016	Health, Health-Related Quality of Life, and Quality of Life: What is the Difference?. (2016). Brazier, John ; Karimi, Milad. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:7:d:10.1007_s40273-016-0389-9. Full description at Econpapers \|\| Download paper	9
9	2017	The Valuation of Informal Care in Cost-of-Illness Studies: A Systematic Review. (2017). oliva, juan ; del Pozo-Rubio, Raul ; Pea-Longobardo, Luz Maria ; Trapero-Bertran, Marta ; Oliva-Moreno, Juan. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:3:d:10.1007_s40273-016-0468-y. Full description at Econpapers \|\| Download paper	8
10	2019	Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. (2019). Deshpande, Abhishek ; Zhang, LU ; Nghiem, Van T ; Chiyaka, Edward T ; Le, Phuc ; Mullen, Patricia Dolan. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:2:d:10.1007_s40273-018-0735-1. Full description at Econpapers \|\| Download paper	7
11	2018	Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Luo, Nan ; Bonsel, Gouke J ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8. Full description at Econpapers \|\| Download paper	7
12	2013	Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement. (2013). Husereau, Don ; Greenberg, Dan ; Carswell, Chris ; Briggs, Andrew ; Petrou, Stavros ; Drummond, Michael ; Mauskopf, Josephine ; Augustovski, Federico ; Loder, Elizabeth ; Moher, David. In: PharmacoEconomics. RePEc:spr:pharme:v:31:y:2013:i:5:p:361-367. Full description at Econpapers \|\| Download paper	6
13	2020	Review of Valuation Methods of Preference-Based Measures of Health for Economic Evaluation in Child and Adolescent Populations: Where are We Now and Where are We Going?. (2020). Devlin, Nancy ; Rivero-Arias, Oliver ; Rowen, Donna ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00873-7. Full description at Econpapers \|\| Download paper	6
14	2018	German Value Set for the EQ-5D-5L. (2018). Graf von der Schulenburg, Johann ; Greiner, Wolfgang ; J-Matthias Graf von der Schulenburg, ; Ludwig, Kristina. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8. Full description at Econpapers \|\| Download paper	5
15	2022	Productivity of Working at Home and Time Allocation Between Paid Work, Unpaid Work and Leisure Activities During a Pandemic. (2022). Brouwer, Werner ; Kanters, Tim A ; Sajjad, Ayesha ; Exel, Job ; Roijen, Leona Hakkaart-Van. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:1:d:10.1007_s40273-021-01078-7. Full description at Econpapers \|\| Download paper	5
16	2020	International Valuation Protocol for the EQ-5D-Y-3L. (2020). Shah, Koonal ; Devlin, Nancy ; Oppe, Mark ; Ramos-Goi, Juan M ; Rivero-Arias, Oliver ; Kreimeier, Simone ; Stolk, Elly. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:7:d:10.1007_s40273-020-00909-3. Full description at Econpapers \|\| Download paper	5
17	2017	International Regulations and Recommendations for Utility Data for Health Technology Assessment. (2017). Hout, Ben ; Chevrou-Severac, Helene ; Zouraq, Ismail Azzabi ; Rowen, Donna. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0544-y. Full description at Econpapers \|\| Download paper	5
18	2018	A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F ; Buchholz, Ines. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5. Full description at Econpapers \|\| Download paper	5
19	2019	Spillover Effects on Caregiversâ and Family Membersâ Utility: A Systematic Review of the Literature. (2019). Prosser, Lisa A ; James, Lyndon P ; Wittenberg, Eve. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-019-00768-7. Full description at Econpapers \|\| Download paper	5
20	2014	A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials. (2014). White, Ian ; Gomes, Manuel ; Faria, Rita ; EPSTEIN, DAVID. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:12:p:1157-1170. Full description at Econpapers \|\| Download paper	4
21	2023	Modelling the Cost-Effectiveness of Diagnostic Tests. (2023). Snowsill, Tristan. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:4:d:10.1007_s40273-023-01241-2. Full description at Econpapers \|\| Download paper	4
22	2018	Discounting in Economic Evaluations. (2018). Claxton, Karl ; Brouwer, Werner ; Attema, Arthur. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:7:d:10.1007_s40273-018-0672-z. Full description at Econpapers \|\| Download paper	4
23	2021	The Economic Burden of Adults with Major Depressive Disorder in the United States (2010 and 2018). (2021). Simes, Mark ; Sisitsky, Tammy ; Fournier, Andree-Anne ; Greenberg, Paul E ; Kessler, Ronald C ; Koenigsberg, Sarah H ; Berman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01019-4. Full description at Econpapers \|\| Download paper	4
24	2018	Using Latent Class Analysis to Model Preference Heterogeneity in Health: A Systematic Review. (2018). , John ; John , ; Thayer, Winter Maxwell ; Zhou, MO. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0575-4. Full description at Econpapers \|\| Download paper	4
25	2012	Valuation of the Child Health Utility 9D Index. (2012). Stevens, Katherine. In: PharmacoEconomics. RePEc:spr:pharme:v:30:y:2012:i:8:p:729-747. Full description at Econpapers \|\| Download paper	4
26	2021	The Challenges of Measuring Informal Care Time: A Review of the Literature. (2021). Sutton, Matt ; Grande, Gunn ; Lau, Yiu-Shing ; Urwin, Sean. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:11:d:10.1007_s40273-021-01053-2. Full description at Econpapers \|\| Download paper	4
27	2017	A Review of Generic Preference-Based Measures for Use in Cost-Effectiveness Models. (2017). Brazier, John ; Chevrou-Severac, Helene ; Rowen, Donna ; Ara, Roberta. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-017-0545-x. Full description at Econpapers \|\| Download paper	4
28	2014	How to Estimate Productivity Costs in Economic Evaluations. (2014). Brouwer, Werner ; Krol, Marieke. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:335-344. Full description at Econpapers \|\| Download paper	4
29	2019	Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe. (2019). Niewada, Maciej ; Graczyk, Katarzyna ; Jakubczyk, Micha ; Golicki, Dominik. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:9:d:10.1007_s40273-019-00811-7. Full description at Econpapers \|\| Download paper	4
30	2019	Combining the Power of Artificial Intelligence with the Richness of Healthcare Claims Data: Opportunities and Challenges. (2019). Sraer, David ; Greenberg, Paul ; Thesmar, David ; Veliche, Razvan ; Dadson, Nick ; Pinheiro, Lisa. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:6:d:10.1007_s40273-019-00777-6. Full description at Econpapers \|\| Download paper	3
31	2015	A Primer on Marginal EffectsâPart I: Theory and Formulae. (2015). Bergtold, Jason ; Jain, Rahul ; Onukwugha, Eberechukwu. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:1:p:25-30. Full description at Econpapers \|\| Download paper	3
32	2015	A Review of the Development and Application of Generic Multi-Attribute Utility Instruments for Paediatric Populations. (2015). Chen, Gang ; Ratcliffe, Julie. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:10:p:1013-1028. Full description at Econpapers \|\| Download paper	3
33	2021	Productivity-Adjusted Life-Years: A New Metric for Quantifying Disease Burden. (2021). Liew, Danny ; Zomer, Ella ; Ackerman, Ilana N ; Ademi, Zanfina. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:3:d:10.1007_s40273-020-00999-z. Full description at Econpapers \|\| Download paper	3
34	2015	The Economic Costs of Type 2 Diabetes: A Global Systematic Review. (2015). Suhrcke, Marc ; Archangelidi, Olga ; Seuring, Till. In: PharmacoEconomics. RePEc:spr:pharme:v:33:y:2015:i:8:p:811-831. Full description at Econpapers \|\| Download paper	3
35	2006	Generic Health-Related Quality-of-Life Assessment in Children and Adolescents. (2006). Wille, Nora ; Bullinger, Monika ; Erhart, Michael ; Nickel, Jennifer ; Ravens-Sieberer, Ulrike ; Wetzel, Ralf. In: PharmacoEconomics. RePEc:spr:pharme:v:24:y:2006:i:12:p:1199-1220. Full description at Econpapers \|\| Download paper	3
36	2020	Experience-Based Swedish TTO and VAS Value Sets for EQ-5D-5L Health States. (2020). Leidl, Reiner ; Gerdtham, Ulf-G. ; Ulf- G. Gerdtham, ; Teni, Fitsum Sebsibe ; Burstrom, Kristina ; Henriksson, Martin ; Rolfson, Ola ; Helgesson, Gert ; Ulf-G. Gerdtham, . In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:8:d:10.1007_s40273-020-00905-7. Full description at Econpapers \|\| Download paper	3
37	2020	Feasibility, Validity and Differences in Adolescent and Adult EQ-5D-Y Health State Valuation in Australia and Spain: An Application of BestâWorst Scaling. (2020). Gorostiza, Inigo ; Garcia-Lorenzo, Borja ; Catchpool, Max ; Dalziel, Kim ; Rivero-Arias, Oliver ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:5:d:10.1007_s40273-020-00884-9. Full description at Econpapers \|\| Download paper	3
38	2020	A French Value Set for the EQ-5D-5L. (2020). Oppe, Mark ; Ramos, Juan Manuel ; Ludwig, Kristina ; Andrade, Luiz Flavio ; Pouvourville, Gerard. In: PharmacoEconomics. RePEc:spr:pharme:v:38:y:2020:i:4:d:10.1007_s40273-019-00876-4. Full description at Econpapers \|\| Download paper	3
39	2019	The Inclusion of Spillover Effects in Economic Evaluations: Not an Optional Extra. (2019). Brouwer, Werner. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:4:d:10.1007_s40273-018-0730-6. Full description at Econpapers \|\| Download paper	3
40	2017	The Societal Cost of Schizophrenia: A Systematic Review. (2017). Jin, Huajie ; Mosweu, Iris. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:1:d:10.1007_s40273-016-0444-6. Full description at Econpapers \|\| Download paper	3
41	2022	Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures. (2022). Lancsar, Emily ; Devlin, Nancy ; Roberts, Nia ; Ratcliffe, Julie ; Daher, Shahd ; Wong, Germaine ; Khan, Kamran ; Mulhern, Brendan ; Chen, Gang ; Hayes, Alison ; Howell, Martin ; Dalziel, Kim ; Huynh, Elisabeth ; Craig, Jonathan ; Freijser, Louise ; Bailey, Cate ; Kwon, Joseph ; Howard, Kirsten ; Smith, Sarah ; Harrison, Conrad ; Petrou, Stavros. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:4:d:10.1007_s40273-021-01128-0. Full description at Econpapers \|\| Download	3
42	2014	Reconceptualising the External Validity of Discrete Choice Experiments. (2014). Swait, Joffre ; Lancsar, Emily. In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:10:p:951-965. Full description at Econpapers \|\| Download paper	3
43	2016	AdViSHE: A Validation-Assessment Tool of Health-Economic Models for Decision Makers and Model Users. (2016). , ; Vemer, P ; Feenstra, T L ; Al, M J ; Ramos, Corro I. In: PharmacoEconomics. RePEc:spr:pharme:v:34:y:2016:i:4:d:10.1007_s40273-015-0327-2. Full description at Econpapers \|\| Download paper	3
44	2021	Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension. (2021). Chen, Gang ; Xie, Shitong ; Brazier, John E ; Wu, Jing ; Wang, Xiaohui ; Jiang, Jie ; Hu, Ming ; Feng, DA ; Bai, Gengliang. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:5:d:10.1007_s40273-020-00997-1. Full description at Econpapers \|\| Download paper	3
45	2022	Correction to: Systematic Review of Conceptual, Age, Measurement and Valuation Considerations for Generic Multidimensional Childhood Patient-Reported Outcome Measures. (2022). Lancsar, Emily ; Devlin, Nancy ; Wong, Germaine ; Khan, Kamran ; Mulhern, Brendan ; Chen, Gang ; Hayes, Alison ; Howell, Martin ; Dalziel, Kim ; Huynh, Elisabeth ; Craig, Jonathan ; Freijser, Louise ; Bailey, Cate ; Kwon, Joseph ; Howard, Kirsten ; Smith, Sarah ; Harrison, Conrad ; Petrou, Stavros ; Roberts, Nia ; Ratcliffe, Julie ; Daher, Shahd. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:4:d:10.1007_s40273-022-01135-9. Full description at Econpapers \|\|	3
46	2014	Assessing the Value of Healthcare Interventions Using Multi-Criteria Decision Analysis: A Review of the Literature. (2014). Orfanos, Panagiotis ; Marsh, Kevin ; Caro, Jaime ; Neasham, David ; Lanitis, Tereza . In: PharmacoEconomics. RePEc:spr:pharme:v:32:y:2014:i:4:p:345-365. Full description at Econpapers \|\| Download paper	3
47	2022	Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations. (2022). Staniszewska, Sophie ; Bekker-Grob, Esther ; Pwu, Raoh-Fang ; Augustovski, Federico ; Petrou, Stavros ; Drummond, Michael ; Mullins, Daniel C ; Husereau, Don ; Mauskopf, Josephine ; Loder, Elizabeth ; Greenberg, Dan ; Chaiyakunapruk, Nathorn ; Caulley, Lisa ; Carswell, Chris ; Briggs, Andrew H. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:6:d:10.1007_s40273-021-01112-8. Full description at Econpapers \|\| Download Jointly Modelling Economics and Epidemiology to Support Public Policy Decisions for the COVID-19 Response: A Review of UK Studies. (2021). Walker, Simon ; Metry, Andrew ; Duarte, Ana ; Sculpher, Mark ; Panovska-Griffiths, Jasmina ; Wong, Ruth. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:8:d:10.1007_s40273-021-01045-2. Full description at Econpapers \|\| Download paper	2
49	2017	The Cost of Relapse in Schizophrenia. (2017). McCrone, Paul ; Pennington, Mark. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0515-3. Full description at Econpapers \|\| Download paper	2
50	2018	Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review. (2018). Lancsar, Emily ; Gu, Yuanyuan ; Ghijben, Peter ; Zavarsek, Silva. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:3:d:10.1007_s40273-017-0586-1. Full description at Econpapers \|\| Download paper	2

Citing documents used to compute impact factor: 25

Year	Title
2024
2024
2024	Development of the What Matters 2 Adults (WM2A) wellbeing measure for Aboriginal and Torres Strait Islander adults. (2024). Dickson, M ; Anderson, K ; Mulhern, B ; Garvey, G ; Jaure, A ; Howard, K ; Cass, A ; Whop, L J ; Cunningham, J ; Gall, A ; Howell, M ; Ratcliffe, J ; Viney, R. In: Social Science & Medicine. RePEc:eee:socmed:v:347:y:2024:i:c:s0277953624001382. Full description at Econpapers \|\| Download paper
2024
2024
2024	Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required. (2024). Sculpher, Mark ; Lomas, James ; Woods, Beth ; Claxton, Karl ; Weatherly, Helen. In: Health Economics. RePEc:wly:hlthec:v:33:y:2024:i:4:p:804-819. Full description at Econpapers \|\| Download paper
2024	Marginal cost per QALY estimates: What are they good for?. (2024). Cookson, Graham ; Sampson, Chris. In: Health Policy. RePEc:eee:hepoli:v:142:y:2024:i:c:s0168851024000460. Full description at Econpapers \|\| Download paper
2024	Risk preferences over health: Empirical estimates and implications for medical decision-making. (2024). Lakdawalla, Darius N ; Phelps, Charles E ; Doctor, Jason N ; Baid, Drishti ; Mulligan, Karen. In: Journal of Health Economics. RePEc:eee:jhecon:v:94:y:2024:i:c:s016762962400002x. Full description at Econpapers \|\| Download paper
2024
2024	Understanding UK public views on normative decisions made to value health-related quality of life in children: A qualitative study. (2024). Keetharuth, Anju ; Rowen, Donna ; Powell, Philip A ; Mukuria, Clara. In: Social Science & Medicine. RePEc:eee:socmed:v:340:y:2024:i:c:s0277953623008638. Full description at Econpapers \|\| Download paper
2024	Who should value childrens health and how? An international Delphi study. (2024). Powell, Philip A ; Shah, Koonal ; Rowen, Donna ; Mukuria, Clara ; Keetharuth, Anju. In: Social Science & Medicine. RePEc:eee:socmed:v:355:y:2024:i:c:s027795362400580x. Full description at Econpapers \|\| Download paper
2024	Evaluation of the public policy impacts on Monkeypox in Brazil. (2024). Oliveira, Angelo Marcio ; de Melo, Carlos Jefferson. In: Evaluation and Program Planning. RePEc:eee:epplan:v:103:y:2024:i:c:s0149718924000156. Full description at Econpapers \|\| Download paper
2024
2024
2024
2024	A happiness approach to valuing health states for children. (2024). Dalziel, Kim ; Chen, Gang ; Devlin, Nancy ; Huang, LI. In: Social Science & Medicine. RePEc:eee:socmed:v:348:y:2024:i:c:s0277953624002466. Full description at Econpapers \|\| Download paper
2024
2024
2024
2024
2024	The Health Technology Assessment Approach of The Economic Value of Diagnostic Test: A Literature Review. (2024). Zaporozhets, Vera ; de Donder, Philippe ; Bardey, David. In: Documentos CEDE. RePEc:col:000089:021041. Full description at Econpapers \|\| Download paper
2024
2024
2024
2024

Recent citations

Recent citations received in 2023

Year	Citing document
2023	Values in Modelling: Video Series Development and Evaluation Survey. (2023). Murphy, David ; Adibi, Amin ; McLean, Alison ; Werker, Greg ; Easterbrook, Adam ; Harvard, Stephanie. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:21:y:2023:i:5:d:10.1007_s40258-023-00820-w. Full description at Econpapers \|\| Download paper
2023	Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. (2023). Reginster, Jean-Yves ; Caminis, John ; Wang, Yamei ; Mathew, Jake ; Pearman, Leny ; Singer, Andrea J ; Silverman, Stuart S ; Hiligsmann, Mickael. In: PharmacoEconomics. RePEc:spr:pharme:v:41:y:2023:i:7:d:10.1007_s40273-023-01270-x. Full description at Econpapers \|\| Download paper

Recent citations received in 2022

Year	Citing document
2022	Where do measures of health, social care and wellbeing fit within a wider measurement framework? Implications for the measurement of quality of life and the identification of bolt-ons. (2022). Mulhern, Brendan ; Finch, Aureliano Paolo. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622006761. Full description at Econpapers \|\| Download paper
2022	The health cost of reducing hospital bed capacity. (2022). Henriksson, Martin ; Siverskog, Jonathan. In: Social Science & Medicine. RePEc:eee:socmed:v:313:y:2022:i:c:s0277953622007055. Full description at Econpapers \|\| Download paper
2022	. Full description at Econpapers \|\| Download paper
2022	. Full description at Econpapers \|\| Download paper
2022	Response to Comment on âAn Integrated Pharmacokinetic-Pharmacodynamic-Pharmacoeconomic Modeling Method to Evaluate Treatments for Adults with Schizophreniaâ. (2022). Wang, Xiaofeng ; Kraan, Carla W ; Houwing, Natalie ; Piena, Marjanne A ; Bennison, Craig ; Waters, Heidi. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:12:d:10.1007_s40273-022-01213-y. Full description at Econpapers \|\| Download paper
2022	An EQ-5D-Y-3L Value Set for Belgium. (2022). Ramos-Goi, Juan M ; Tollenaar, Nafthali H ; Roudijk, Bram ; Dewilde, Sarah. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01187-x. Full description at Econpapers \|\| Download paper
2022	Value Set for the EQ-5D-Y-3L in Hungary. (2022). Brodszky, Valentin ; Finch, Aureliano Paolo ; Yang, Zhihao ; Bato, Alex ; Ruzsa, Gabor ; Rencz, Fanni. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01190-2. Full description at Econpapers \|\| Download paper
2022	Analytical Considerations When Anchoring Discrete Choice Experiment Values Using Composite Time Trade-Off Data: The Case of EQ-5D-Y-3L. (2022). Rivero-Arias, Oliver ; Shah, Koonal K ; Norman, Richard ; Kreimeier, Simone ; Devlin, Nancy J ; Mott, David J. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01214-x. Full description at Econpapers \|\| Download paper
2022	Estimating an EQ-5D-Y-3L Value Set for China. (2022). Jing, Mingxia ; Li, Shunping ; Yu, Xiao ; Feng, DA ; Fang, YU ; Wu, Jing ; Wang, Pei ; Luo, Nan ; Jiang, Jie ; Huang, Weidong ; Yang, Zhihao ; Zheng, Bin. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01216-9. Full description at Econpapers \|\| Download paper
2022	Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L. (2022). Gu, Ning Yan ; Pickard, Simon A ; Nazari, Jonathan L. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01222-x. Full description at Econpapers \|\| Download paper
2022	EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions. (2022). Stolk, Elly ; Viney, Rosalie ; Roudijk, Bram ; Devlin, Nancy. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:2:d:10.1007_s40273-022-01226-7. Full description at Econpapers \|\| Download paper
2022	Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China. (2022). Chen, Yixuan ; Li, Huangqianyu ; Wei, Yuxuan ; Zhang, Yichen ; Guan, Xiaodong ; Shi, Luwen ; Guo, Yiran. In: PharmacoEconomics. RePEc:spr:pharme:v:40:y:2022:i:7:d:10.1007_s40273-022-01161-7. Full description at Econpapers \|\| Download paper

Recent citations received in 2021

Year	Citing document
2021	Value judgments in a COVID-19 vaccination model: A case study in the need for public involvement in health-oriented modelling. (2021). Adibi, Amin ; Symons, John ; Winsberg, Eric ; Harvard, Stephanie. In: Social Science & Medicine. RePEc:eee:socmed:v:286:y:2021:i:c:s0277953621006559. Full description at Econpapers \|\| Download paper
2021	. Full description at Econpapers \|\| Download paper
2021	. Full description at Econpapers \|\| Download paper
2021	. Full description at Econpapers \|\| Download paper
2021	. Full description at Econpapers \|\| Download paper
2021	The Health and Productivity Burden of Depression in South Korea. (2021). Ademi, Zanfina ; Liew, Danny ; Rhee, Yongjoo ; Zomer, Ella. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:19:y:2021:i:6:d:10.1007_s40258-021-00649-1. Full description at Econpapers \|\| Download paper
2021	EQ-5D-Y Population Norms for Japanese Children and Adolescents. (2021). Fukuda, Takashi ; Shiroiwa, Takeru. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:11:d:10.1007_s40273-021-01063-0. Full description at Econpapers \|\| Download paper
2021	Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting. (2021). Postma, Maarten J ; Villar, Fernando Antoanzas ; Garcia, Paula Rojas ; Pol, Simon. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:12:d:10.1007_s40273-021-01104-8. Full description at Econpapers \|\| Download paper
2021	Authorsâ Reply to Comment on âCost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndromeâ. (2021). Veenstra, David L ; Carlson, Josh J ; Neuberger, Edward E. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:4:d:10.1007_s40273-021-01006-9. Full description at Econpapers \|\| Download paper
2021	Putting Stakeholder Engagement at the Center of Health Economic Modeling for Health Technology Assessment in the United States. (2021). Bright, Jennifer L ; Linthicum, Mark T ; Malik, Erica Defur ; Xie, Richard Z. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01036-3. Full description at Econpapers \|\| Download paper
2021	The Growing Burden of Major Depressive Disorders (MDD): Implications for Researchers and Policy Makers. (2021). Nellesen, Dave ; Greenberg, Paul ; Proudman, David. In: PharmacoEconomics. RePEc:spr:pharme:v:39:y:2021:i:6:d:10.1007_s40273-021-01040-7. Full description at Econpapers \|\| Download paper

10 most frequent citing series

#	Series	H	Cites
1	The European Journal of Health Economics / Springer	29	338
2			286
3	Social Science & Medicine / Elsevier	77	192
4	PharmacoEconomics / Springer	20	110
5	Health Economics / John Wiley & Sons, Ltd.	74	90
6	Health Policy / Elsevier	38	79
7	PLOS ONE / Public Library of Science	56	72
8	Journal of choice modelling / Elsevier	21	26
9	Applied Health Economics and Health Policy / Springer	15	23
10	Sustainability / MDPI	67	22
11	PharmacoEconomics - Open / Springer	5	17